We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

507 hedge funds and large institutions have $14.4B invested in Bio-Rad Laboratories Class A in 2021 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 171 increasing their positions, 198 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more call options, than puts

Call options by funds: $76.4M | Put options by funds: $54.5M

16% more capital invested

Capital invested by funds: $12.4B → $14.4B (+$2.01B)

11% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 44

0% more funds holding in top 10

Funds holding in top 10: 7 → 7 (0)

0.12% less ownership

Funds ownership: 78.65% → 78.53% (-0.12%)

0% less funds holding

Funds holding: 508 → 507 (-1)

14% less repeat investments, than reductions

Existing positions increased: 171 | Existing positions reduced: 198

Holders
507
Holders Change
-1
Holders Change %
-0.2%
% of All Funds
8.88%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
49
Increased
171
Reduced
198
Closed
44
Calls
$76.4M
Puts
$54.5M
Net Calls
+$21.8M
Net Calls Change
+$60.4M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$244M
2
SSA
Schonfeld Strategic Advisors
New York
+$51.6M
3
SEI Investments
SEI Investments
Pennsylvania
+$50.3M
4
Franklin Resources
Franklin Resources
California
+$48.5M
5
Millennium Management
Millennium Management
New York
+$32.8M

Top Sellers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
-$75.2M
2
PCH
Polar Capital Holdings
United Kingdom
-$71.7M
3
BlackRock
BlackRock
New York
-$63.8M
4
HP
Hound Partners
New York
-$46.6M
5
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$42.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCWA
501
Ten Capital Wealth Advisors
Washington
$2K – – –
SSC
502
Syverson Strege & Co
Iowa
$2K +$2.25K +3 New
Nisa Investment Advisors
503
Nisa Investment Advisors
Missouri
$1.51K -$730K -975 -33%
CWP
504
Concord Wealth Partners
Virginia
$1K – – –
GWS
505
Glassman Wealth Services
Virginia
$1K – – –
Walleye Capital
506
Walleye Capital
New York
$570 +$572K +764 New
BBHC
507
Brown Brothers Harriman & Co
New York
$88 – – –
HP
508
Hound Partners
New York
– -$46.6M -72,264 Closed
EAM
509
Exane Asset Management
France
– -$33M -51,223 Closed
Balyasny Asset Management
510
Balyasny Asset Management
Illinois
– -$37.8M -50,518 Closed
AC
511
Armistice Capital
New York
– -$11.6M -18,000 Closed
TCM
512
Tygh Capital Management
Oregon
– -$7.78M -12,075 Closed
Axa
513
Axa
France
– -$4.64M -7,200 Closed
HF
514
HRT Financial
New York
– -$3.19M -4,951 Closed
ACM
515
Asymmetry Capital Management
California
– -$1.92M -2,979 Closed
QC
516
Quadrature Capital
United Kingdom
– -$1.78M -2,767 Closed
BAM
517
Blueshift Asset Management
New Jersey
– -$1.4M -2,167 Closed
QSS
518
Quantitative Systematic Strategies
Florida
– -$1.17M -1,812 Closed
PP
519
Paloma Partners
Connecticut
– -$903K -1,403 Closed
SI
520
Symmetry Investments
Jersey
– -$870K -1,350 Closed
TI
521
Trexquant Investment
Connecticut
– -$825K -1,280 Closed
CANY
522
Caxton Associates (New York)
New York
– -$795K -1,234 Closed
CC
523
Centiva Capital
New York
– -$724K -1,124 Closed
TA
524
Tamarack Advisers
California
– -$644K -1,000 Closed
XT
525
XTX Topco
Cayman Islands
– -$530K -822 Closed
19 20
21
22 23

BIO Hedge Fund Activity: Q3 2021 in Review

507 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q3 2021, worth a combined $14.4B — up 16% from $12.4B a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new BIO positions and 44 closed out — a net gain of 5 holders — while 171 added to existing stakes and 198 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $244M. The largest seller was Deutsche Bank, cutting an estimated $75.2M.

  • 507 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q3 2021, down from 508 in Q2 2021.
  • Funds reported $14.4B of Bio-Rad Laboratories Class A stock for Q3 2021, up 16% quarter-over-quarter.
  • 49 funds opened new Bio-Rad Laboratories Class A positions in Q3 2021 and 44 closed out, a net change of +5 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q3 2021 was Fidelity Investments, an estimated $244M added.
  • The largest Bio-Rad Laboratories Class A seller in Q3 2021 was Deutsche Bank, an estimated $75.2M sold.

Based on aggregated 13F filings for Q3 2021.